Masimo Corporation · NASDAQ:MASI

Masimo — Q4 2017 Earnings Presentation

15 slides from Masimo's earnings presentation, Feb 27, 2018

  1. Slide 1: Q4 2017 Results Supplemental Presentation to Earnings Press Release

    © 2017 Masimo. All Rights Reserved. Q4 2017 Results Supplemental Presentation to Earnings Press Release February 27, 2018

  2. Slide 2: Forward-Looking Statements

    © 2018 Masimo. All Rights Reserved. All statements other than statements of historical facts contained herein that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements including, in particular, the statements

  3. Slide 3: Non-GAAP Financial Measures

    © 2018 Masimo. All Rights Reserved. Non-GAAP Financial Measures The non-GAAP financial measures contained herein are a supplement to the corresponding financial measures prepared in accordance with U.S. generally accepted accounting principles (GAAP). The non-GAAP financial measures presented exclud

  4. Slide 4: Masimo Today

    © 2018 Masimo. All Rights Reserved. Masimo Today ~$808M annual product revenue 1 >140 countries Innovator in noninvasive patient monitoring technologies >100 Million patients impacted each year 2 Leader in pulse oximetry Primary pulse oximetry technology at 17 of the top 20 hospitals listed in the 2

  5. Slide 5: Execution of our Initial Year Plan

    © 2018 Masimo. All Rights Reserved. Execution of our Initial 10 Year Plan ► Product revenue rose from $200M in 2007 to $741M in 2017 1 ► Clinical success for SET® and rainbow (i.e. PVi ®, SpHb®, ORi® and SpCO®) ► Technology expansion ► NomoLine™ capnography ► SedLine™ brain function monitoring ► O3®

  6. Slide 6: Embarking on New Seven Year Plan

    © 2018 Masimo. All Rights Reserved. ► Our customers and partners are embracing us ► Targeting revenue growth of 8%-10% ► Targeting long-term operating profit margin of 30% ► Targets do not include contributions from products in pipeline or M&A ► We are a 29 year-old company that has the passion of a

  7. Slide 7: Fourth Quarter 2017 Financial Results

    © 2018 Masimo. All Rights Reserved. Fourth Quarter 2017 Financial Results

  8. Slide 8: Fourth Quarter 2017 Highlights

    © 2018 Masimo. All Rights Reserved. Fourth Quarter 2017 Highlights ► Total revenue, including royalty and other revenue, increased 22.9% to $225.2 million ► Product revenue increased 13.4% to $199.2 million ► GAAP net income of $0.4 million, or $0.01 cent per diluted share, which included a charge o

  9. Slide 9: Fourth Quarter 2017 P&L Performance

    © 2018 Masimo. All Rights Reserved. Fourth Quarter 2017 P&L Performance ($ in millions, except per share amounts) Q4 2017 Q4 2016 Increase / (Decrease) Performance Highlights Total Revenue $ 225.2 $ 183.2 22.9% Product Revenue $ 199.2 $ 175.7 13.4% Solid growth in both our U.S and international regi

  10. Slide 10: 2018 Guidance and Adoption of Non-GAAP Financial Measures

    © 2018 Masimo. All Rights Reserved. 2018 Guidance and Adoption of Non-GAAP Financial Measures

  11. Slide 11: Adoption of Non-GAAP Financial Measures

    © 2018 Masimo. All Rights Reserved. Adoption of Non-GAAP Financial Measures ► In response to investor feedback and more aligned with peer practices ► We believe these changes increase transparency and better reflect the underlying financial performance of the business ► Creates more meaningful compa

  12. Slide 12: 2018 Financial Guidance

    © 2018 Masimo. All Rights Reserved. 2018 Financial Guidance1 1 Masimo 2018 financial guidance as of February 27, 2018 2 Please refer to our Non-GAAP financial measures and definitions contained herein ($ in millions, except per share amounts) 2018 Guidance Performance Highlights GAAP Non-GAAP 2 Tota

  13. Slide 13: Driving Shareholder Value Through Growth and Profitability

    © 2018 Masimo. All Rights Reserved. Driving Shareholder Value Through Growth and Profitability Product Revenue (in Millions) Adjusted EBITDA 2 (in Millions) Non-GAAP EPS 2 ($ per share) 1 1 1 1 Masimo 2018 financial guidance as of February 27, 2018 2 Please refer to our Non-GAAP financial measures a

  14. Slide 14: Investment Highlights

    © 2018 Masimo. All Rights Reserved. Investment Highlights Improve Patient Care and Reduce Cost of Care through Innovation-Ultimate Way to Drive Shareholder Value Grow revenues at multiples of the market (8-10% growth) Target long-term gross product margins of ~70% and operating profit margins of ~30

  15. Slide 15: © 2018 Masimo. All Rights Reserved.

    © 2018 Masimo. All Rights Reserved.

Masimo — Q4 2017 Earnings Presentation on 6ix